A random glitch in Google Maps caused pandemonium on German roadways during Ascension Day. For some reason, the app was showing dozens of road closures. However, those roads were not actually closed.

Though scientists know that wake-sleep glitch is what's happening during a sleep paralysis episode, they're not entirely sure why. But there are several factors that can increase the risk of ...

GENEVA — Geneva’s airport, Switzerland’s second-largest, will cut the number of aircraft that can land by 20 percent starting Monday due to a technical issue, the country’s air traffic ...

Mondelēz International, the maker of snacks like Oreo, Chips Ahoy! and Nutter Butter, has filed a trademark infringement lawsuit against Aldi, accusing the supermarket of “blatantly” copying ...

Right, so. Over the past day or so, a pretty serious glitch has been plaguing Helldivers 2 - it let cheeky players spawn in so many stratagems at once the game would crash. Thankfully, Arrowhead's ...

Bankrupt genetic-testing firm 23andMe agreed to sell its data bank, which once contained DNA samples from about 15 million people, to the drug developer Regeneron Pharmaceuticals for $256 million.

Procter & Gamble will cut 7,000 jobs over the next two years, as the Tide detergent maker contends with an uncertain spending environment, fueled in part by US tariffs that have roiled numerous ...

US-based yoghurt and creamers maker Chobani has bought local frozen-foods business Daily Harvest. In a joint statement sent to Just Food, the companies said the deal, struck for an undisclosed sum ...

WASHINGTON (AP) — Ford is recalling more than a million vehicles due to a software issue that can cause the rearview camera to malfunction, increasing the chance of an accident, government auto ...

Axon CEO Rick Smith topped the highest-paid CEOs list, reportedly raking in $165 million through stock incentives at his company, selling Tasers, security cameras, drones, and VR training.

Ozempic and Wegovy maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen on Friday over concerns the company is losing its first-mover advantage in the highly competitive obesity drug market.